Beam Therapeutics Inc.

NASDAQ:BEAM

25.51 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 377.70960.9251.8440.0240.01800
Cost of Revenue 20.01222.57716.441103.1795.4070.650.011
Gross Profit 357.69738.34335.403-103.155-5.389-0.65-0.011
Gross Profit Ratio 0.9470.6290.683-4,298.125-299.38900
Reseach & Development Expenses 437.381311.594387.087103.17954.61933.8735.859
General & Administrative Expenses 116.81387.80557.22229.60520.55311.8682.021
Selling & Marketing Expenses -20.012000000
SG&A 96.80187.80557.22229.60520.55311.8682.021
Other Expenses 0000-0.071-10.040.378
Operating Expenses 534.182399.399444.309132.78475.17245.7417.88
Operating Income -176.485-338.479-392.465-132.76-75.154-45.741-7.88
Operating Income Ratio -0.467-5.556-7.57-5,531.667-4,175.22200
Total Other Income Expenses Net 45.32478.30121.827-61.832-3.172-71.289-0.122
Income Before Tax -131.161-260.178-370.638-194.592-78.326-116.738-8.002
Income Before Tax Ratio -0.347-4.271-7.149-8,108-4,351.44400
Income Tax Expense 1.3663.41-29.27861.8320.116-70.9970.5
Net Income -132.527-263.588-341.36-256.424-78.442-115.257-8.002
Net Income Ratio -0.351-4.327-6.584-10,684.333-4,357.88900
EPS -1.72-3.76-5.31-5.49-1.53-3.28-0.62
EPS Diluted -1.72-3.76-5.31-5.49-1.53-3.28-0.62
EBITDA -156.473-401.483-414.301-64.625-69.23616.158-7.369
EBITDA Ratio -0.414-6.59-7.991-2,692.708-3,846.44400